We are currently experiencing intermittent difficulty during Premium user registration. We appreciate your patience as we investigate.

Title Collection Author Date
The Cheapest Stock in the World Stock Insight Andrew Willis 23-12-22
3 Vaccine Stocks That Could Get a Boost on China Outbreaks Stock Insight Vikram Barhat 07-12-22
Why These Biotech Stocks Are Outperforming the Market Stock Insight Lauren Solberg 24-11-22
U.S. Inflation Reduction Act Could Hurt These 3 Stocks Fund Insight Vikram Barhat 09-11-22
Moderna: Stock of the Week Stock Insight Andrew Willis 02-09-22
Stock of the Week: Bausch Health Stock Insight Andrew Willis 08-08-22
Why is Bausch so Cheap? Stock Insight Andrew Willis 17-06-22
Merck's COVID-19 Drug Posts Poor Data; No Change to FVE Stock Insight Damien Conover, CFA 21-04-22
Why is Moderna so Cheap? Stock Insight Andrew Willis 11-03-22
Five Star Stocks on Deep Discount Stock Insight Vikram Barhat 30-06-21
Stock of the Week: Moderna Stock Insight Andrew Willis 10-05-21
No Vaccine IP? No Problem! Stock Insight Karen Andersen, CFA 09-05-21
10 ESG Investments for 2021 - Part 1 ESG Investing Andrew Willis 29-04-21
Stock of the Week: Curaleaf Stock Insight Andrew Willis 22-03-21
4 Healthy Stocks for Your Portfolio Stock Insight Vikram Barhat 24-02-21
We Still Expect a Strong U.S. Economic Recovery Market Insights Preston Caldwell 09-11-20
Positive News From COVID-19 Vaccines Don't Change FVEs Stock Insight Karen Andersen, CFA 15-10-20
Contenders in the Vaccine Race Stock Insight Vikram Barhat 14-10-20
Waiting for the Cannabis Hit: 7 Stocks for Your Watchlist Stock Insight Lex Hall 29-09-20
What a Covid-19 Vaccine Means for Investors Market Insights Karen Andersen, CFA 22-07-20
Cannabis, Take Two Market Insights Andrew Willis 01-06-20
Coronavirus vaccine progress accelerates Market Insights Karen Andersen, CFA 14-05-20
2 attractive drugmakers with secure dividends Stock Insight Damien Conover, CFA 14-05-20
Is Remdesivir-maker Gilead Sciences a 'buy'? Stock Insight Karen Andersen, CFA 11-05-20
Near-term approval of Gilead's Remdesivir likely Stock Insight Karen Andersen, CFA 29-04-20
Path to a vaccine emerges as investors overreact Market Insights Karen Andersen, CFA 20-03-20
Health-care stocks: No fear of contagion Stock Insight Andrew Willis 06-02-20
The cannabis investing outlook in 5 charts Stock Insight Kristoffer Inton 17-01-20
Markets are moving on a tightrope: Manager Manager Insight Michael Ryval 07-11-19
The impact of opioid litigation on pharma stocks Video Ruth Saldanha 24-09-19
Is weed a responsible investment? Special Report Andrew Willis 10-07-19
Page   1 of 1
© Copyright 2023 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy